RxDoctor Payments Data

Kimberly Johnson, NP

Family · Mooresville, NCNPI 1518272707

Payments from drug & device makers

$2,569in general payments, 2019–2025

Across 134 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$512
  • AbbVie$401
  • Pfizer$314
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$302
  • Scilex Pharmaceuticals Inc.$170
  • Azurity Pharmaceuticals, Inc.$157
  • plus $713 from 14 others

What the payments were for

  • Food & beverage$2,569100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,569 in reported general payments places this provider in the 85th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$48,394
Medicare patients
61
Services billed
523

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate33$55,627
BelbucaBuprenorphine Hcl55$41,573
UbrelvyUbrogepant28$39,288
NucyntaTapentadol Hcl35$37,148
RelistorMethylnaltrexone Bromide13$35,403
MovantikNaloxegol Oxalate51$18,885
QuliptaAtogepant16$17,411
Xtampza ErOxycodone Myristate29$15,061
Buprenorphine40$12,546
Aimovig AutoinjectorErenumab-Aooe16$11,324
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen398$10,552
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen300$8,916
Nucynta ErTapentadol Hcl17$8,442
SymproicNaldemedine Tosylate18$8,133
OxycontinOxycodone Hcl11$4,617

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Nucynta, Xtampza Er, Nucynta Er$512$102,224136 claims
AbbVieUbrelvy, Qulipta$401$56,69944 claims
PfizerNurtec Odt$314$55,62733 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$302$35,40313 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$45$14,458106 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,522 family providers in North Carolina.

Other family in Mooresville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →